Formulation of nanoliposome-encapsulated bevacizumab (Avastin): Statistical optimization for enhanced drug encapsulation and properties evaluation.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of pharmaceutics"
DOI: 10.1016/j.ijpharm.2020.119895
Abstract: Bevacizumab (Avastin®), an anti-vascular endothelial growth factor, is one of the most effective drugs widely used to inhibit ocular angiogenesis. Nanoliposomes were recruited to improve the accessibility of bevacizumab (BVZ) during treatment. To optimize drug… read more here.
Keywords: nlp bvz; bevacizumab avastin; formulation; drug ... See more keywords
New Seawater Dielectric Constant Parametrization and Application to SMOS Retrieved Salinity
Sign Up to like & getrecommendations! Published in 2023 at "IEEE Transactions on Geoscience and Remote Sensing"
DOI: 10.1109/tgrs.2023.3257923
Abstract: The accuracy of the Sea Surface Salinity (SSS) retrieved from L-Band radiometer measurements is strongly dependent on the reliability of the dielectric constant model. Two new parametrizations were recently developed based on one hand on… read more here.
Keywords: parametrization; smos; dielectric constant; salinity ... See more keywords
SUN-340 Prolactinoma Response to Bevacizumab Is Influenced by Tumor Progression Stage at the Beginning of Treatment
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the Endocrine Society"
DOI: 10.1210/js.2019-sun-340
Abstract: Abstract Anti-VEGF therapy is being implemented as second line drug for aggressive pituitary adenomas that do not respond to conventional treatments. Although it is approved for treatment of several cancers, many of them acquire resistance.… read more here.
Keywords: tumor progression; mice; bvz; treatment ... See more keywords
Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14246087
Abstract: Simple Summary Around 30% of children with optic pathway glioma (OPG) require next order systemic anticancer therapy (SAT) in case of progression. Bevacizumab (BVZ) is considered an effective subsequent SAT for pediatric low grade glioma.… read more here.
Keywords: optic pathway; progression; toxicity; bvz ... See more keywords
Assessment of In-Situ Gelling Microemulsion Systems upon Temperature and Dilution Condition for Corneal Delivery of Bevacizumab
Sign Up to like & getrecommendations! Published in 2021 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics13020258
Abstract: Bevacizumab (BVZ), a recombinant humanized monoclonal antibody, has recently been proposed as a topical application in the treatment of anterior segment neovascularization; however, as there are some disadvantages in the administration of common eye-drops, ophthalmic… read more here.
Keywords: corneal; bevacizumab; dilution; delivery ... See more keywords